PCV26 Lifetime Cost-Effectiveness Analysis of Ticagrelor in Patients With Acute Coronary Syndromes Based on the Plato Trial: A Singapore Health Care Perspective

dc.contributor.author

Chin, CT

dc.contributor.author

Mellström, C

dc.contributor.author

Chua, TS

dc.contributor.author

Matchar, DB

dc.date.accessioned

2021-05-11T08:08:29Z

dc.date.available

2021-05-11T08:08:29Z

dc.date.issued

2012-11

dc.date.updated

2021-05-11T08:08:27Z

dc.identifier.issn

1098-3015

dc.identifier.uri

https://hdl.handle.net/10161/22895

dc.language

en

dc.publisher

Elsevier BV

dc.relation.ispartof

Value in Health

dc.relation.isversionof

10.1016/j.jval.2012.08.193

dc.title

PCV26 Lifetime Cost-Effectiveness Analysis of Ticagrelor in Patients With Acute Coronary Syndromes Based on the Plato Trial: A Singapore Health Care Perspective

dc.type

Journal article

duke.contributor.orcid

Matchar, DB|0000-0003-3020-2108

pubs.begin-page

A632

pubs.end-page

A633

pubs.issue

7

pubs.organisational-group

School of Medicine

pubs.organisational-group

Duke Clinical Research Institute

pubs.organisational-group

Duke Global Health Institute

pubs.organisational-group

Pathology

pubs.organisational-group

Medicine, General Internal Medicine

pubs.organisational-group

Duke

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

University Institutes and Centers

pubs.organisational-group

Institutes and Provost's Academic Units

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Medicine

pubs.publication-status

Published

pubs.volume

15

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Lifetime cost-effectiveness analysis of ticagrelor in patients with acute coronary syndromes based on the PLATO trial.pdf
Size:
1.32 MB
Format:
Adobe Portable Document Format